Filtered By:
Condition: Heart Failure
Countries: China Health
This page shows you your search results in order of relevance. This is page number 16.
Order by Relevance | Date
Total 240 results found since Jan 2013.
Association between polymorphisms in connexin 40 gene (Cx40) and risk of atrial fibrillation: a meta-analysis based on 3,452 subjects
CONCLUSIONS: The Cx40 polymorphisms were positively associated with AF in both populations, especially on -44 polymorphism.PMID:37382580 | DOI:10.1080/1354750X.2023.2227361
Source: Biomarkers - June 29, 2023 Category: Research Authors: Zheng Lian Zheng Ma Zhi-Li Zhang Pei-Lin Liu Guo-Yong Zhang Cai-Xia Guo Source Type: research
Impact of age on characteristics, performance measures and outcomes of inpatients for heart failure in Beijing, China
ConclusionsHF patients aged ≥75 years had distinct clinical profiles, received worse in-hospital therapies and experienced higher in-hospital and 1 year mortality.
Source: ESC Heart Failure - August 2, 2023 Category: Cardiology Authors: Cong Yuan,
Liu He,
Xin Du,
Chao Jiang,
Shi ‐Jun Xia,
Xin Zhao,
Song‐Nan Li,
Cai‐Hua Sang,
De‐Yong Long,
Jian‐Zeng Dong,
Chang‐Sheng Ma Tags: Original Article Source Type: research
Association between polymorphisms in connexin 40 gene (Cx40) and risk of atrial fibrillation: a meta-analysis based on 3,452 subjects
CONCLUSIONS: The Cx40 polymorphisms were positively associated with AF in both populations, especially on -44 polymorphism.PMID:37382580 | DOI:10.1080/1354750X.2023.2227361
Source: Biomarkers - June 29, 2023 Category: Research Authors: Zheng Lian Zheng Ma Zhi-Li Zhang Pei-Lin Liu Guo-Yong Zhang Cai-Xia Guo Source Type: research
Effects of Compound Danshen Dripping Pills on Ventricular Remodeling and Cardiac Function after Acute Anterior Wall ST-Segment Elevation Myocardial Infarction (CODE-AAMI): Protocol for a Randomized Placebo-Controlled Trial
This study is designed to evaluate the efficacy and safety of CDDP in improving ventricular remodeling and cardiac function after AAMI on a larger scale.MethodsThis study is a multi-center, randomized, double-blind, placebo-controlled, parallel-group clinical trial. The total of 268 patients with AAMI after primary percutaneous coronary intervention (pPCI) will be randomly assigned 1:1 to the CDDP group (n=134) and control group (n=134) with a follow-up of 48 weeks. Both groups will be treated with standard therapy of ST-segment elevation myocardial infarction (STEMI), with the CDDP group administrating 20 tablets of CDDP ...
Source: Chinese Journal of Integrative Medicine - September 1, 2023 Category: Internal Medicine Source Type: research
Correlation of neck circumference, coronary calcification severity and cardiovascular events in Chinese elderly patients with acute coronary syndromes
CONCLUSIONS: NC is closely associated with MetS and its components, coronary calcification and lesion degree, and MACEs. NC could be used as surrogate of CACS to predict the coronary condition and prognosis of elderly patients with ACS.PMID:37679211 | DOI:10.1016/j.atherosclerosis.2023.117242
Source: Atherosclerosis - September 7, 2023 Category: Cardiology Authors: Peiqing Tian Yixuan Liu Jiayu Wang Liyun Xing Xianwei Huang Caihua Fu Cuicui Yuan Ping Liu Source Type: research
Report on Cardiovascular Health and Diseases in China 2022: an Updated Summary
Biomed Environ Sci. 2023 Aug 20;36(8):669-701. doi: 10.3967/bes2023.106.ABSTRACTIn the past 30 years, the accessibility and quality index of medical care have made remarkable progress in China, ranking the first among middle-income countries. Many cardiovascular technologies are at or near the world's leading level, and significant progress has been achieved in China solving the problem of "treatment difficulty" of cardiovascular diseases (CVD). However, due to the prevalence of unhealthy lifestyles among Chinese residents, a huge population with CVD risk factors, accelerated population aging, and other reasons, the incide...
Source: Biomedical and Environmental Sciences : BES - September 15, 2023 Category: Biomedical Science Authors: Writing Committee Of The Report On Cardiovascular Health And Diseases In China The Source Type: research
